Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Frontiers in OncologyOpen Access

POLE-mutated endometrial cancer: new perspectives on the horizon?

View Full Paper
Ask AI
Bookmark
Share

Authors

DFDaniele FanaleLCLidia Rita CorsiniPPPaola Piraino

Discussion

Loading...

Member takes

Overview

Review demonstrates the clinical significance of POLE mutations in endometrial cancer, highlighting potential immunotherapy responses.

Key Points

  • Ultramutated endometrial cancer shows favorable prognostic outcomes, and can account for 8-10% of cases.
  • Emerging evidence suggests that POLE mutational status may enhance responsiveness to immunotherapy in patients.
  • Germline and somatic POLE genetic alterations are linked to genome instability, impacting tumor development.
  • Routine genetic testing for POLE mutations could improve prevention and surveillance strategies for at-risk patients.

Cite This Study

Fanale et al. (2025) studied this question.

synapsesocial.com/papers/68c1d24654b1d3bfb60f840bhttps://doi.org/10.3389/fonc.2025.1633260
View Full Paper
Ask AI
Bookmark
Share